The Crohn’s disease exclusion diet, used in those with mild to moderate illness, aims to ease symptoms and reduce inflammation by altering the gut microbiome.

Encala’s structured-lipid technology has demonstrated the ability to enhance oral absorption of lipid-soluble medications, ...

There were no studies that specifically studied the effect of enteral lipids in infants at risk of liver disease or who have liver disease due to prolonged need for artificial nutrition secondary to ...

The global enteral food and devices market growth is driven by an aging population, rising chronic illnesses (cancer, ...

Exclusive enteral feeding from birth does not increase the risk of necrotising enterocolitis or reduce hospital admission in ...

Parenteral nutrition (PN)-associated cholestasis (PNAC) is frequently diagnosed in premature infants; however, not all ...

AGA clinical practice guidelines for inflammatory bowel disease management have undergone “major shifts” in recent years, placing diet front and center and urging patients to adhere to Mediterranean ...

Why real-food enteral nutrition often isn’t covered—and how reimbursement policies conflict with food-first clinical guidance.

How nutrition therapy supports recovery, rehabilitation, and quality of life in patients with chronic critical illness and post–ICU syndrome.

News and commentary from the world of gastroenterology and hepatology ...

Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growthTYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) - ...